Reaction Details Report a problem with these data
Target
CREB-binding protein [1081-1197]
Ligand
BDBM511302
Substrate
n/a
Meas. Tech.
CBP AlphaScreen Assay
IC50
5.00±n/a nM
Citation
 Le, K; Soth, MJ; Jones, P; Cross, JB; Carroll, CL; McAfoos, TJ; Mandal, PK Imidazopiperazine inhibitors of transcription activating proteins US Patent  US11058688 Publication Date 7/13/2021 
Target
Name:
CREB-binding protein [1081-1197]
Synonyms:
CBP | CBP_HUMAN | CREB-binding protein (CBP)(1081-1197) | CREBBP
Type:
Enzyme Catalytic Domain
Mol. Mass.:
13987.94
Organism:
Homo sapiens (Human)
Description:
Q92793[1081-1197]
Residue:
117
Sequence:
RKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG
  
Inhibitor
Name:
BDBM511302
Synonyms:
3-cyclopropyl-1-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-N-methyl-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxamide | US11058688, Example 3
Type:
Small organic molecule
Emp. Form.:
C25H29F2N7O
Mol. Mass.:
481.5409
SMILES:
CNC(=O)N1CCn2c(C1)c(nc2C1CC1)N1CCCc2cc(-c3cnn(C)c3)c(cc12)C(F)F
Structure:
Search PDB for entries with ligand similarity: